These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 38456579)
21. Performance of Cardiovascular Disease Risk Scores in People Diagnosed With Type 2 Diabetes: External Validation Using Data From the National Scottish Diabetes Register. Read SH; van Diepen M; Colhoun HM; Halbesma N; Lindsay RS; McKnight JA; McAllister DA; Pearson ER; Petrie JR; Philip S; Sattar N; Woodward M; Wild SH; Diabetes Care; 2018 Sep; 41(9):2010-2018. PubMed ID: 30002197 [TBL] [Abstract][Full Text] [Related]
22. Trends in prevalence of cardiovascular risk factors from 2002 to 2012 among youth early in the course of type 1 and type 2 diabetes. The SEARCH for Diabetes in Youth Study. Kim G; Divers J; Fino NF; Dabelea D; Lawrence JM; Reynolds K; Bell RA; Mayer-Davis E; Crume T; Pettitt DJ; Pihoker C; Liu L Pediatr Diabetes; 2019 Sep; 20(6):693-701. PubMed ID: 30903717 [TBL] [Abstract][Full Text] [Related]
23. Central hemodynamics are associated with cardiovascular disease and albuminuria in type 1 diabetes. Theilade S; Hansen TW; Rossing P Am J Hypertens; 2014 Sep; 27(9):1152-9. PubMed ID: 24627444 [TBL] [Abstract][Full Text] [Related]
24. [Applications of the NDR and DIAL models for risk prediction on cardiovascular disease in patients with type 2 diabetes in Ningbo]. Li QQ; Liang JY; Wang JM; Shen P; Sun YX; Chen Q; Wu JG; Lu P; Zhang JY; Lin HB; Tang X; Gao P Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Jun; 43(6):945-952. PubMed ID: 35725354 [No Abstract] [Full Text] [Related]
25. Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study. Lind M; Bounias I; Olsson M; Gudbjörnsdottir S; Svensson AM; Rosengren A Lancet; 2011 Jul; 378(9786):140-6. PubMed ID: 21705065 [TBL] [Abstract][Full Text] [Related]
26. Incremental value of risk factor variability for cardiovascular risk prediction in individuals with type 2 diabetes: results from UK primary care electronic health records. Xu Z; Arnold M; Sun L; Stevens D; Chung R; Ip S; Barrett J; Kaptoge S; Pennells L; Di Angelantonio E; Wood AM Int J Epidemiol; 2022 Dec; 51(6):1813-1823. PubMed ID: 35776101 [TBL] [Abstract][Full Text] [Related]
27. A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION-Europe) study. Simmons RK; Borch-Johnsen K; Lauritzen T; Rutten GE; Sandbæk A; van den Donk M; Black JA; Tao L; Wilson EC; Davies MJ; Khunti K; Sharp SJ; Wareham NJ; Griffin SJ Health Technol Assess; 2016 Aug; 20(64):1-86. PubMed ID: 27583404 [TBL] [Abstract][Full Text] [Related]
28. A prospective study of cardiovascular disease in patients with Type 2 diabetes. 6.3 years of follow-up. Rius Riu F; Salinas Vert I; Lucas Martín A; Romero González R; Sanmartí Sala A J Diabetes Complications; 2003; 17(5):235-42. PubMed ID: 12954150 [TBL] [Abstract][Full Text] [Related]
29. Level of physical activity associated with risk of cardiovascular diseases and mortality in patients with type-2 diabetes: report from the Swedish National Diabetes Register. Zethelius B; Gudbjörnsdottir S; Eliasson B; Eeg-Olofsson K; Cederholm J; Eur J Prev Cardiol; 2014 Feb; 21(2):244-51. PubMed ID: 24227183 [TBL] [Abstract][Full Text] [Related]
30. Glycated Hemoglobin, Prediabetes, and the Links to Cardiovascular Disease: Data From UK Biobank. Welsh C; Welsh P; Celis-Morales CA; Mark PB; Mackay D; Ghouri N; Ho FK; Ferguson LD; Brown R; Lewsey J; Cleland JG; Gray SR; Lyall DM; Anderson JJ; Jhund PS; Pell JP; McGuire DK; Gill JMR; Sattar N Diabetes Care; 2020 Feb; 43(2):440-445. PubMed ID: 31852727 [TBL] [Abstract][Full Text] [Related]
31. Risk prediction of cardiovascular disease in type 2 diabetes: a risk equation from the Swedish National Diabetes Register. Cederholm J; Eeg-Olofsson K; Eliasson B; Zethelius B; Nilsson PM; Gudbjörnsdottir S; Diabetes Care; 2008 Oct; 31(10):2038-43. PubMed ID: 18591403 [TBL] [Abstract][Full Text] [Related]
32. Polygenic risk scores in cardiovascular risk prediction: A cohort study and modelling analyses. Sun L; Pennells L; Kaptoge S; Nelson CP; Ritchie SC; Abraham G; Arnold M; Bell S; Bolton T; Burgess S; Dudbridge F; Guo Q; Sofianopoulou E; Stevens D; Thompson JR; Butterworth AS; Wood A; Danesh J; Samani NJ; Inouye M; Di Angelantonio E PLoS Med; 2021 Jan; 18(1):e1003498. PubMed ID: 33444330 [TBL] [Abstract][Full Text] [Related]
33. Cardiovascular disease risk prediction using automated machine learning: A prospective study of 423,604 UK Biobank participants. Alaa AM; Bolton T; Di Angelantonio E; Rudd JHF; van der Schaar M PLoS One; 2019; 14(5):e0213653. PubMed ID: 31091238 [TBL] [Abstract][Full Text] [Related]
34. New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR). Eeg-Olofsson K; Cederholm J; Nilsson PM; Zethelius B; Svensson AM; Gudbjörnsdóttir S; Eliasson B J Intern Med; 2010 Nov; 268(5):471-82. PubMed ID: 20804517 [TBL] [Abstract][Full Text] [Related]
35. Diabetic retinopathy as an independent marker of cardiovascular disease in type 1 diabetes: Results from a nationwide longitudinal matched case-cohort study. Mabala DS; Stokholm L; Andersen N; Andresen J; Bek T; Heegaard S; Hajari J; Højlund K; Kawasaki R; Laugesen CS; Möller S; Pedersen FN; Schielke KC; Thykjær AS; Grauslund J Acta Ophthalmol; 2024 Sep; 102(6):635-642. PubMed ID: 38345204 [TBL] [Abstract][Full Text] [Related]
36. Low 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 levels are independently associated with macroalbuminuria, but not with retinopathy and macrovascular disease in type 1 diabetes: the EURODIAB prospective complications study. Engelen L; Schalkwijk CG; Eussen SJ; Scheijen JL; Soedamah-Muthu SS; Chaturvedi N; Fuller JH; Stehouwer CD Cardiovasc Diabetol; 2015 May; 14():67. PubMed ID: 26025465 [TBL] [Abstract][Full Text] [Related]
37. Shortened Relative Leukocyte Telomere Length Is Associated With Prevalent and Incident Cardiovascular Complications in Type 2 Diabetes: Analysis From the Hong Kong Diabetes Register. Cheng F; Luk AO; Tam CHT; Fan B; Wu H; Yang A; Lau ESH; Ng ACW; Lim CKP; Lee HM; Chow E; Kong AP; Keech AC; Joglekar MV; So WY; Jenkins AJ; Chan JCN; Hardikar AA; Ma RCW Diabetes Care; 2020 Sep; 43(9):2257-2265. PubMed ID: 32661111 [TBL] [Abstract][Full Text] [Related]
38. Development and validation of a cardiovascular risk prediction model in type 1 diabetes. McGurnaghan SJ; McKeigue PM; Read SH; Franzen S; Svensson AM; Colombo M; Livingstone S; Farran B; Caparrotta TM; Blackbourn LAK; Mellor J; Thoma I; Sattar N; Wild SH; Gudbjörnsdottir S; Colhoun HM; Diabetologia; 2021 Sep; 64(9):2001-2011. PubMed ID: 34106282 [TBL] [Abstract][Full Text] [Related]
39. Body mass index, estimated glucose disposal rate and vascular complications in type 1 diabetes: Beyond glycated haemoglobin. Helliwell R; Warnes H; Kietsiriroje N; Campbell M; Birch R; Pearson SM; Ajjan RA Diabet Med; 2021 May; 38(5):e14529. PubMed ID: 33502032 [TBL] [Abstract][Full Text] [Related]
40. Maternal diabetes during pregnancy and early onset of cardiovascular disease in offspring: population based cohort study with 40 years of follow-up. Yu Y; Arah OA; Liew Z; Cnattingius S; Olsen J; Sørensen HT; Qin G; Li J BMJ; 2019 Dec; 367():l6398. PubMed ID: 31801789 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]